Medartis Holding AG (MEDA)

Currency in CHF
89.40
-1.30(-1.43%)
Closed·
MEDA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
88.5091.00
52 wk Range
70.6097.50
Key Statistics
Bid/Ask
88.00 / 93.00
Prev. Close
90.7
Open
91
Day's Range
88.5-91
52 wk Range
70.6-97.5
Volume
2.53K
Average Volume (3m)
7.32K
1-Year Change
6.5554%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MEDA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
98.33
Upside
+9.99%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Medartis Holding AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 98.33
(+9.99% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy97.00+8.50%87.00Upgrade07/07/2026
UBS
Hold87.00-2.68%92.00Maintain24/03/2026
UBS
Hold90.00+0.67%-New Coverage31/07/2025

Earnings

Latest Release
17/03/2026
EPS / Forecast
0.79 / --
Revenue / Forecast
146.22M / --
EPS Revisions
Last 90 days

Compare MEDA to Peers and Sector

Metrics to compare
MEDA
Peers
Sector
Relationship
P/E Ratio
133.3x21.6x−0.4x
PEG Ratio
0.96−0.230.00
Price/Book
4.0x2.5x2.6x
Price / LTM Sales
4.1x1.8x3.0x
Upside (Analyst Target)
8.5%11.3%53.5%
Fair Value Upside
Unlock19.7%9.0%Unlock

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal, and kerimedical products. The company was incorporated in 1997 and is headquartered in Basel, Switzerland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
544.89K4.38%48.71M
Other Institutional Investors
4.27M34.34%382.15M
Public Companies & Retail Investors
7.63M61.28%681.85M
Total
12.45M100.00%1.11B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bank of America Corporation8.89%1,106,39098,911
Endeavour Vision SA7.11%884,95779,115

People Also Watch

16.10
MIKN
-1.53%
20.70
RSGN
-0.10%
18.54
CALN
-1.49%
353.50
MOBN
+1.43%
381.50
LEHN
-1.68%

FAQ

What Is the Medartis (Switzerland: MEDA) Share Price Today?

The Medartis stock price today is 89.40 CHF.

What Stock Exchange Does Medartis (MEDA) Trade On?

Medartis is listed and trades on the Switzerland Stock Exchange.

What Is the Ticker (Stock Symbol) for Medartis?

The stock symbol (also called a 'ticker') for Medartis is "MEDA."

What Is the Current Medartis Market Capitalisation?

As of today, Medartis (Switzerland: MEDA) market cap is 1.11B CHF.

What Is Medartis's (MEDA) Earnings Per Share (TTM)?

The Medartis EPS is currently 0.67 (Trailing Twelve Months).

Is MEDA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Medartis moving averages and other technical indicators, the daily buy/sell signal for MEDA stock is Buy.

How Many Times Has Medartis Stock Split?

Medartis has split 0 times. (See the MEDA stock split history page for full effective split date and price information.)

How Many Employees Does Medartis Have?

Medartis has 1259 employees, based on their latest Companies House report.

What is the current trading status of Medartis (Switzerland: MEDA)?

As of 19/07/2026, Medartis (MEDA) is trading at a share price of 89.40 CHF, with a previous close of 90.70 CHF. The stock has fluctuated within a day range of 88.50 CHF to 91.00 CHF, while its 52-week range spans from 70.60 CHF to 97.50 CHF.

What Is Medartis (MEDA) Price Target According to Analysts?

The average 12-month price target for Medartis is 98.33 CHF, with a high estimate of 102 CHF and a low estimate of 96 CHF. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +9.99% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.